BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11697954)

  • 1. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
    George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
    J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient chemoenzymatic synthesis of O-linked sialyl oligosaccharides.
    Blixt O; Allin K; Pereira L; Datta A; Paulson JC
    J Am Chem Soc; 2002 May; 124(20):5739-46. PubMed ID: 12010048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
    Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
    Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of O-glycan biosynthesis in human colon cancer tissues.
    Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
    Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
    Biochemistry; 1995 Mar; 34(9):2925-36. PubMed ID: 7534477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of tumor associated sialyl-T-glycopeptides and their immunogenicity.
    Komba S; Werdelin O; Jensen T; Meldal M
    J Pept Sci; 2000 Dec; 6(12):585-93. PubMed ID: 11192238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic glycopeptides for the development of tumour-selective vaccines.
    Kunz H
    J Pept Sci; 2003 Sep; 9(9):563-73. PubMed ID: 14552419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
    Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
    J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple column synthesis of a library of T-cell stimulating Tn-antigenic glycopeptide analogues for the molecular characterization of T-cell-glycan specificity.
    Frische K; Meldal M; Werdelin O; Mouritsen S; Jensen T; Galli-Stampino L; Bock K
    J Pept Sci; 1996; 2(4):212-22. PubMed ID: 9231328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.
    Marcelo F; Garcia-Martin F; Matsushita T; Sardinha J; Coelho H; Oude-Vrielink A; Koller C; André S; Cabrita EJ; Gabius HJ; Nishimura S; Jiménez-Barbero J; Cañada FJ
    Chemistry; 2014 Dec; 20(49):16147-55. PubMed ID: 25324212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
    Dziadek S; Brocke C; Kunz H
    Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
    Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
    Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoenzymatic synthesis of a MUC1 glycopeptide carrying non-natural sialyl TF-beta O-glycan.
    Tanaka E; Nakahara Y; Kuroda Y; Takano Y; Kojima N; Hojo H; Nakahara Y
    Biosci Biotechnol Biochem; 2006 Oct; 70(10):2515-22. PubMed ID: 17031043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
    Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
    J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
    Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
    Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
    Dziadek S; Kunz H
    Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor-associated glycopeptides by lectins: the peptide context modulates carbohydrate recognition.
    Madariaga D; Martínez-Sáez N; Somovilla VJ; Coelho H; Valero-González J; Castro-López J; Asensio JL; Jiménez-Barbero J; Busto JH; Avenoza A; Marcelo F; Hurtado-Guerrero R; Corzana F; Peregrina JM
    ACS Chem Biol; 2015 Mar; 10(3):747-56. PubMed ID: 25457745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.